Fjell Capital LLC Makes New Investment in Danaher Co. (NYSE:DHR)

Fjell Capital LLC purchased a new position in shares of Danaher Co. (NYSE:DHR) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,978 shares of the conglomerate’s stock, valued at approximately $454,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. AMF Tjanstepension AB bought a new position in Danaher in the 3rd quarter worth approximately $5,923,000. Howard Capital Management Group LLC boosted its holdings in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares during the period. Allworth Financial LP grew its position in shares of Danaher by 6.1% in the third quarter. Allworth Financial LP now owns 5,337 shares of the conglomerate’s stock valued at $1,484,000 after purchasing an additional 307 shares in the last quarter. Arkadios Wealth Advisors raised its stake in shares of Danaher by 1.8% during the 3rd quarter. Arkadios Wealth Advisors now owns 3,572 shares of the conglomerate’s stock valued at $993,000 after purchasing an additional 64 shares during the period. Finally, Inscription Capital LLC boosted its stake in Danaher by 75.5% in the 3rd quarter. Inscription Capital LLC now owns 1,981 shares of the conglomerate’s stock worth $551,000 after purchasing an additional 852 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Trading Down 0.2 %

NYSE DHR opened at $210.65 on Wednesday. The firm has a market cap of $150.56 billion, a PE ratio of 39.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The stock has a 50-day moving average of $225.79 and a 200-day moving average of $246.04. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 earnings per share. As a group, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is 24.24%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Barclays decreased their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a report on Friday, December 13th. Wells Fargo & Company reduced their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Finally, Guggenheim initiated coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective on the stock. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.